![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SHREEGANES.png)
Share the post "Shareholding Pattern: Shareholding Pattern Shree Ganesh Biotech (india) FY(Q2-Sep 2024-2025)"
Shareholding results provide a detailed breakdown of ownership in a company, including the percentage of shares held by different types of investors. This data is essential for understanding the concentration of ownership and the influence of major stakeholders. Evaluating shareholding results can help investors make informed decisions about the company’s market position and future prospects. Shree Ganesh Biotech (india) has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on (Q2-Sep 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 0 | 0 | 0 | 0 | 0 |
| Public | 39.86 Cr | 39.86 Cr | 98.58 | 98.58 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 56.65 Lakh | 56.65 Lakh | 1.42 | 1.42 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 0% in both June 2024 and September 2024. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 98.58% in both June 2024 and September 2024. This indicates that the Public control over the company did not change during this period. FIIs (Foreign Institutional Investors) shareholding remained at 1.42% from June 2024 to September 2024. , indicating no change in the investment levels by foreign institutions in the company.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
“”
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 32.15 Cr | 32.16 Cr | 80.65 | 80.67 | + 0.02 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 5.88 Cr | 5.83 Cr | 14.74 | 14.63 | -0.11 % |
| Non Resident Indians (NRIs) | 72.00 Lakh | 70.87 Lakh | 1.81 | 1.78 | -0.03 % |
| Any Other (specify) | 47.22 Lakh | 51.43 Lakh | 1.18 | 1.29 | + 0.11 % |
| HUF | 46.35 Lakh | 50.46 Lakh | 1.16 | 1.27 | + 0.11 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.02 %.Observations show a significant difference of -0.11 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -0.03 % in Non Resident Indians (NRIs)’s financial performance between quarters.Leading the way to higher stakeholding, Any Other (specify) has significantly boosted stakeholding by an impressive 0.11 %.Leading the way to higher stakeholding, HUF has significantly boosted stakeholding by an impressive 0.11 %.
[my_shortcode1 values=”Shree Ganesh Biotech (india)”]
